Access Selected Content from Financial Times on Moneycontrol Pro

Access Selected Content from

Financial Times on Moneycontrol Pro

SENSEX
NIFTY 50
Hang Seng
Taiwan Weighted
MCX GOLD DEC 04
MCX SILVER DEC 04
USD/INR
EUR/INR80.0630

SENSEX
NIFTY 50
NIFTY MIDCAP 100
S&P BSE MIDCAP
Hang Seng
Taiwan Weighted
DAX
Nasdaq
MCX GOLD DEC 04
MCX SILVER DEC 04
MCX CRUDEOIL DEC 18
MCX NATURALGAS DEC 28
USD/INR
EUR/INR
GBP/INR
JPY/INR

Nifty could see resistance at 13,150 zone: IIFL's Anu Jain

Asian shares grind lower amid vaccine doubts, economic concern

Gold trades flat; may face resistance at Rs 48,900 per 10 gm

Rupee slumps 35 paise to 74.76 against US dollar

gilead

Gilead's COVID-19 antiviral remdesivir gets conditional EU clearance

Gilead's COVID-19 antiviral remdesivir gets conditional EU clearance

By Reuters

view more

Videos on gilead

Gilead's drug remdesivir to become standard of care for COVID-19, says Fauci

Gilead's drug remdesivir to become standard of care for COVID-19, says Fauci

By Reuters

Gilead's remdesivir is not a magic bullet against COVID-19, says Biocon's Kiran Mazumdar Shaw

Gilead's remdesivir is not a magic bullet against COVID-19, says Biocon's Kiran Mazumdar Shaw

By Surabhi Upadhyay , Anuj Singhal

Gilead says experimental drug helps COVID-19 patients, raising hopes in pandemic fight

Gilead says experimental drug helps COVID-19 patients, raising hopes in pandemic fight

By Reuters

more news

Gilead's remdesivir shows promise in COVID-19 study on monkeys

Gilead's remdesivir shows promise in COVID-19 study on monkeys

By Reuters

COVID-19 effect: AstraZeneca approached remdesivir maker Gilead about potential merger, says report

COVID-19 effect: AstraZeneca approached remdesivir maker Gilead about potential merger, says report

By Reuters

Trending on CNBC-TV18

Live TV

recommended for you